Payment overview · 2025
General Payments
$227.80
2 reported records · 2 companies
Healthcare provider profile · identity verified
Lisa Dietz, DO
Allopathic & Osteopathic Physicians|Family Medicine · CLARKSTON, MI · NPI 1629067541
Verified facts
What the public records show
CMS Open Payments records show Lisa Dietz, DO received $227.80 in general payments during 2025 across 2 reported records.
GENZYME CORPORATION accounted for 53.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GENZYME CORPORATION | Unresolved — no canonical attribution shown | $121.35 | 53.3% | 1 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $106.45 | 46.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $227.80 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| DUPIXENT Normalized: dupixent |
Biological | GENZYME CORPORATION | $121.35 | 1 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $106.45 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 562 | 156 |
| Levothyroxine Sodium | Levothyroxine Sodium | 530 | 125 |
| Alprazolam | Alprazolam | 375 | 65 |
| Losartan Potassium | Losartan Potassium | 338 | 85 |
| Amlodipine Besylate | Amlodipine Besylate | 335 | 85 |
| Omeprazole | Omeprazole | 276 | 72 |
| Lisinopril | Lisinopril | 254 | 68 |
| Montelukast Sodium | Montelukast Sodium | 232 | 67 |
| Simvastatin | Simvastatin | 224 | 50 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 213 | 34 |
| Tramadol Hcl | Tramadol Hcl | 194 | 34 |
| Metformin Hcl Er | Metformin Hcl | 183 | 51 |
| Alendronate Sodium | Alendronate Sodium | 174 | 41 |
| Metoprolol Succinate | Metoprolol Succinate | 143 | 35 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 140 | 39 |
| Pravastatin Sodium | Pravastatin Sodium | 140 | 36 |
| Potassium Chloride | Potassium Chloride | 137 | 41 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 137 | 44 |
| Gabapentin | Gabapentin | 134 | 36 |
| Metformin Hcl | Metformin Hcl | 119 | 35 |
| Fluticasone Propionate | Fluticasone Propionate | 114 | 32 |
| Meloxicam | Meloxicam | 114 | 29 |
| Famotidine | Famotidine | 112 | 33 |
| Bupropion Xl | Bupropion Hcl | 108 | 32 |
| Sertraline Hcl | Sertraline Hcl | 102 | 27 |
| Zolpidem Tartrate | Zolpidem Tartrate | 102 | 21 |
| Furosemide | Furosemide | 100 | 34 |
| Jardiance | Empagliflozin | 100 | 29 |
| Hydrochlorothiazide | Hydrochlorothiazide | 99 | 29 |
| Duloxetine Hcl | Duloxetine Hcl | 96 | 24 |
| Pioglitazone Hcl | Pioglitazone Hcl | 94 | 21 |
| Clopidogrel | Clopidogrel Bisulfate | 91 | 21 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 88 | 22 |
| Pantoprazole Sodium | Pantoprazole Sodium | 87 | 23 |
| Metoprolol Tartrate | Metoprolol Tartrate | 86 | 24 |
| Clonazepam | Clonazepam | 85 | 16 |
| Prednisone | Prednisone | 84 | 54 |
| Trazodone Hcl | Trazodone Hcl | 83 | 19 |
| Eliquis | Apixaban | 73 | 16 |
| Valacyclovir | Valacyclovir Hcl | 70 | 20 |
| Ozempic | Semaglutide | 68 | 14 |
| Trulicity | Dulaglutide | 67 | 13 |
| Carvedilol | Carvedilol | 66 | 19 |
| Atenolol | Atenolol | 65 | 11 |
| Diazepam | Diazepam | 65 | 17 |
| Ibuprofen | Ibuprofen | 64 | 18 |
| Fenofibrate | Fenofibrate Nanocrystallized | 62 | 15 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 62 | 19 |
| Allopurinol | Allopurinol | 54 | 14 |
| Azithromycin | Azithromycin | 54 | 47 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 53 | 14 |
| Ezetimibe | Ezetimibe | 52 | 17 |
| Lorazepam | Lorazepam | 52 | suppressed |
| Nystatin | Nystatin | 51 | 18 |
| Pregabalin | Pregabalin | 51 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 50 | 22 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 49 | 14 |
| Januvia | Sitagliptin Phosphate | 48 | 13 |
| Mounjaro | Tirzepatide | 47 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 47 | suppressed |
| Synthroid | Levothyroxine Sodium | 43 | 12 |
| Tamsulosin Hcl | Tamsulosin Hcl | 42 | 14 |
| Buspirone Hcl | Buspirone Hcl | 41 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 40 | suppressed |
| Temazepam | Temazepam | 39 | suppressed |
| Celecoxib | Celecoxib | 38 | 14 |
| Estradiol | Estradiol | 38 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 38 | 14 |
| Escitalopram Oxalate | Escitalopram Oxalate | 37 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 35 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 34 | suppressed |
| Lovastatin | Lovastatin | 33 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 33 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 32 | 13 |
| Divalproex Sodium | Divalproex Sodium | 31 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 31 | suppressed |
| Glipizide Er | Glipizide | 30 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 30 | 13 |
| Risperidone | Risperidone | 30 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 30 | suppressed |
| Fentanyl | Fentanyl | 29 | suppressed |
| Lansoprazole | Lansoprazole | 29 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 22 |
| Enalapril Maleate | Enalapril Maleate | 28 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 28 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 28 | 11 |
| Warfarin Sodium | Warfarin Sodium | 28 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 27 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 27 | suppressed |
| Valsartan | Valsartan | 27 | suppressed |
| Levetiracetam | Levetiracetam | 26 | suppressed |
| Vraylar | Cariprazine Hcl | 26 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 25 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 25 | suppressed |
| Mirtazapine | Mirtazapine | 24 | suppressed |
| Naproxen | Naproxen | 24 | 12 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 24 | 19 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 22 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 22 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 22 | suppressed |
| Ramipril | Ramipril | 22 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 21 | suppressed |
| Fluconazole | Fluconazole | 21 | 15 |
| Glipizide | Glipizide | 21 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 20 | suppressed |
| Irbesartan | Irbesartan | 20 | suppressed |
| Memantine Hcl | Memantine Hcl | 20 | suppressed |
| Methadone Hcl | Methadone Hcl | 20 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 19 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 19 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 19 | suppressed |
| Finasteride | Finasteride | 19 | suppressed |
| Maxalt | Rizatriptan Benzoate | 19 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 19 | 11 |
| Telmisartan | Telmisartan | 19 | suppressed |
| Amoxicillin | Amoxicillin | 18 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 17 | suppressed |
| Levofloxacin | Levofloxacin | 17 | 17 |
| Topiramate | Topiramate | 17 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 17 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 16 | 14 |
| Entresto | Sacubitril/Valsartan | 16 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 16 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 15 | suppressed |
| Chlorthalidone | Chlorthalidone | 15 | suppressed |
| Lamotrigine | Lamotrigine | 15 | suppressed |
| Myrbetriq | Mirabegron | 15 | suppressed |
| Xarelto | Rivaroxaban | 15 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 14 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Premarin | Estrogens, Conjugated | 14 | suppressed |
| Ridaura | Auranofin | 14 | suppressed |
| Brilinta | Ticagrelor | 13 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 13 | 12 |
| Glimepiride | Glimepiride | 13 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 13 | suppressed |
| Ketoconazole | Ketoconazole | 13 | suppressed |
| Metformin Er Osmotic | Metformin Hcl | 13 | suppressed |
| Alyacen | Norethindrone-Ethin. Estradiol | 12 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 12 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 12 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 12 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 12 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 12 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 12 | suppressed |
| Oxycontin | Oxycodone Hcl | 12 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 12 | suppressed |
| Anastrozole | Anastrozole | 11 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 11 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Methocarbamol | Methocarbamol | 11 | suppressed |
| Mirabegron Er | Mirabegron | 11 | suppressed |
| Modafinil | Modafinil | 11 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 11 | suppressed |
| Verapamil Er Pm | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $227.80 · 2 records | GENZYME CORPORATION | CAPLYTA, DUPIXENT | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error